- $1.27bn
- $1.56bn
- $296.45m
- 89
- 33
- 88
- 80
Annual income statement for P10, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 67.4 | 151 | 198 | 242 | 296 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 58.7 | 126 | 155 | 221 | 236 |
| Operating Profit | 8.69 | 25 | 43.4 | 20.9 | 60.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.03 | 3.7 | 35.5 | -3.14 | 28.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 23.8 | 10.8 | 29.4 | -7.77 | 19.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 23.1 | 9.17 | 29.2 | -7.13 | 18.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 23.1 | 9.17 | 29.4 | -7.13 | 18.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.356 | 0.17 | 0.307 | 0.016 | 0.256 |
| Dividends per Share |